Geron (GERN) Net Income (2010 - 2026)
Geron's (GERN) quarterly Net Income came in at -$16.7 million in Q2 2026, down 2.19% year-over-year from -$17.0 million in Q2 2025, and down 367.24% quarter-over-quarter from -$3.6 million in Q1 2026.
Analysis
Geron (GERN) Net Income (2010 - 2026) Analysis & Trends
Geron has disclosed Net Income across 17 years of filings, most recently posting -$16.7 million for Q2 2026.
- In Q2 2026, Net Income fell 2.19% year-over-year to -$16.7 million; the TTM figure through Jun 2026 stood at -$67.3 million (up 21.79% YoY), while the FY2025 annual figure was -$83.1 million, up 51.85% from the prior year.
- Net Income came in at -$16.7 million for Q2 2026 at Geron, down from -$3.6 million in the prior quarter.
- In the past five years, Net Income ranged from a high of -$3.6 million in Q1 2026 to a low of -$67.3 million in Q2 2024.
- Average Net Income over 5 years is -$33.5 million, with a median of -$30.0 million recorded in 2022.
- Year-over-year, Net Income slumped 68.39% in 2023 and surged 81.94% in 2026.
- Over 5 years, Net Income stood at -$42.7 million in 2022, then retreated by 21.75% to -$52.0 million in 2023, then jumped by 54.63% to -$23.6 million in 2024, then declined by 22.02% to -$28.8 million in 2025, then soared by 42.1% to -$16.7 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$16.7 million in Q2 2026, -$3.6 million in Q1 2026, and -$28.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 601.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -290.61 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -16.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.67 Mn |
| Mar 31, 2026 | -3.57 Mn |
| Dec 31, 2025 | -28.79 Mn |
| Sep 30, 2025 | -18.27 Mn |
| Jun 30, 2025 | -16.31 Mn |
| Mar 31, 2025 | -19.75 Mn |
| Dec 31, 2024 | -23.60 Mn |
| Sep 30, 2024 | -26.38 Mn |
| Jun 30, 2024 | -67.32 Mn |
| Mar 31, 2024 | -55.33 Mn |
| Dec 31, 2023 | -52.01 Mn |
| Sep 30, 2023 | -44.71 Mn |
| Jun 30, 2023 | -49.22 Mn |
| Mar 31, 2023 | -38.16 Mn |
| Dec 31, 2022 | -42.72 Mn |
| Sep 30, 2022 | -40.91 Mn |
| Jun 30, 2022 | -29.23 Mn |
| Mar 31, 2022 | -30.69 Mn |
| Dec 31, 2021 | -32.01 Mn |
| Sep 30, 2021 | -26.62 Mn |